Ascend Wellness (OTC:AAWH) Shares Up 1.7% - Should You Buy?

Key Points

• Ascend Wellness Holdings, Inc. (OTC:AAWH) saw its shares rise by 1.7% during mid-day trading, reaching a last traded price of $0.64.
• However, Zacks Research has downgraded the stock to a "strong sell" rating, contributing to an overall average rating of "sell" from analysts.
• The company's financial metrics show a debt-to-equity ratio of 2.61, indicating significant leverage, and it has a market capitalization of $131.03 million.

Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) shot up 1.7% during mid-day trading on Wednesday . The stock traded as high as $0.66 and last traded at $0.64. 186,976 shares traded hands during trading, an increase of 15% from the average session volume of 162,426 shares. The stock had previously closed at $0.63.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Ascend Wellness to a "strong sell" rating in a research report on Tuesday, August 12th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Ascend Wellness currently has an average rating of "Sell".

Ascend Wellness Trading Up 1.7%

The business has a 50 day simple moving average of $0.60 and a 200-day simple moving average of $0.43. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47. The stock has a market capitalization of $131.03 million, a P/E ratio of -1.56 and a beta of 1.17.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.